Physician profile
Tracy Timony
NPI 1063404945
$453.41
in general payments reported to CMS, 2019-2025
10 companies · $94.35 in 2025
The $94.35 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.49 · 2020: $14.75 · 2021: $28.18 · 2022: $21.33 · 2023: $102 · 2024: $177 · 2025: $94.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $114.67 | 2021-2024 | Vraylar |
| Lilly USA, LLC | $99.86 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $63.66 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $51.03 | 2023-2025 | |
| Glaxosmithkline, LLC. | $27.70 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbott Laboratories | $24.19 | 2024 | Eterna |
| Eisai INC. | $21.05 | 2025 | |
| Convatec INC. | $21.03 | 2024 | |
| Exact Sciences Corporation | $15.47 | 2025 | The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $14.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Timony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.